Painchek Share Price and Company Fundamentals
Last traded: Today at 5:59 AM
PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals primarily in Australia and Europe. The company offers PainChek, which uses camera in smartphone and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited. in January 2018. PainChek Limited is based in Sydney, Australia.
|Primary activities||Development and commercialisation of mobile medical applications that are intended to provide pain assessment for individuals who are unable to communicate with their carers.|
|Industry / Sector||Health Information Services / Healthcare|
|Mailing address||35 Lime Street Suite 401 Sydney NSW 2000 Australia|
|Phone / Fax||1800 098 809 /|
|Share registry||BOARDROOM PTY LIMITED|
Painchek does not pay dividends.
As of May 2021, following are the company executives and directors listed on Painchek.
|Mr. Philip Daffas B.Sc., M.B.A., BSc, Dip EENG, MBA, GAICD||MD, CEO & Director||343.57k|
|Mr. Ian Hobson A.C.I.S., F.C.A., M.A.I.C.D., B.BUS, FCA, ACSA, MA||CFO & Company Sec.||55||142.72k|
|Mr. Andrew Hoggan||Head of Operations|
|Mr. Scott Robertson M.B.A.||Chief Technology Officer|
|Prof. Jeff Hughes Ph.D.||Chief Scientific Officer|
|Mr. David Allsopp||Head of Bus. Devel. ANZ|
|Mr. Pete Shergill||Head of Bus. Devel. UK|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Painchek is 68.73M and its enterprise value is 57.45M. The enterprise value to revenue ratio of PCK is 238.93.
The PCK's stocks Beta value is 0.29 making it 71% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Painchek (PCK)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Painchek (ASX:PCK) Frequently Asked Questions
1. What is Painchek's Stock Symbol?
Painchek trades on ASX under the ticker symbol "PCK".
2. What is Painchek's stock price today?
One share of PCK stock can currently be purchased for approximately $0.061.
3. How can I contact Painchek?
Painchek's mailing address is 35 Lime Street Suite 401 Sydney NSW 2000 Australia. The company can be reached via phone at 1800 098 809.
4. What is Painchek's official website?
The official website of Painchek is http://www.painchek.com.
5. Which share registry manages Painchek's stock?
Painchek's stock is managed by BOARDROOM PTY LIMITED.